Hey There, Young Man,
PI is done (October, per news posted by you Message 18083362 ), but only a sentence without numbers mentioned.
I poked around on the National Jewish website today, but found nothing relevant. Not a surprise, we probably won't see anything till the PII is officially announced as enrolling. Can't find anything in PubMed, either. Same old this how we make our library stuff. The nice thing about a rhinitis trial: it doesn't take very long. It was announced in the 2nd quarter PR that it would begin in the end of summer, and in early October it's already done.
In a way, I like Rigel's understated style. Compare to INGN, which put out about half a dozen press releases about how great their gene therapy is while a conference was going on here in SD this past week. Couldn't they have waited and just dumped all their results into one release? Anyhow, I don't think the pump worked.
Meanwhile, Rigel has delivered on their business plan, if not with perfect timeliness. I hear you, though. It would be a little easier to roll the dice if we had some more data about their candidates. However, there could be more news coming from Novartis; there are three programs from which the could select a target (having already chosen an autoimmune candidate). Can't remember if there are any clues as to news flow from Pfizer.
Gower's buys lead me to suspect that at least a bit of this potential news flow will in fact come, and we could now buy for less than he has.
Cheers, Tuck |
